Search for information about a product,
therapeutic area or event

Media, investors, advocacy organizations and others, please contact us here.

Publications

Access Travere’s peer-reviewed publications.

Home » Publications
Year
Therapeutic Area
Product

Results 45

Sort by

Publications FSGS

The Humanistic Burden of Focal Segmental Glomerulosclerosis on Patients and Care‑Partners in the United States

View
Publications Alport syndrome

Dual Inhibition of the Endothelin and Angiotensin Receptor Ameliorates Renal and Inner Ear Pathologies in Alport Mice

View
Publications FSGS

Efficacy and Safety of ACE Inhibitor and Angiotensin Receptor Blocker Therapies in Primary Focal Segmental Glomerulosclerosis Treatment: A Systematic Review and Meta-Analysis

View
Publications FSGS Nephrology

Differentiating Primary and Secondary FSGS Using Non-Invasive Urine Biomarkers

View
Publications FSGS Nephrology

Clinical Characteristics and Histopathology in Adults With Focal Segmental Glomerulosclerosis

View
Publications FSGS Nephrology

Population Pharmacokinetic Analysis of Sparsentan in Healthy Volunteers and Patients with Focal Segmental Glomerulosclerosis

View
Publications IgAN Nephrology

Practical Considerations for the Use of Sparsentan in the Treatment of Patients with IgAN in Clinical Practice

View
Publications IgAN Nephrology

Estimation of Health State Utility Values for Immunoglobulin A Nephropathy: A Time Trade-Off Analysis

View
Publications FSGS

Sparsentan Clinical Trials in Glomerular Diseases: Defining Endpoints and a Path Forward in Light of the Parasol Initiative

View
Publications Nephrology

The Dual Endothelin A and Angiotensin II Type 1 Receptor Antagonist Sparsentan (FILSPARI®) Exhibits a Safe Nonclinical Male Fertility Toxicity Profile

View
Publications FSGS

Epidemiology and Burden of Focal Segmental Glomerulosclerosis Among United States Veterans: An Analysis of Veteran’s Affairs Data

View
Publications Cystinuria

Assessment of Health‐Related Quality of Life in Patients With Cystinuria on Tiopronin Therapy

View